Merck KGaA
MKGAF
$142.89
-$0.11-0.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.89B | 6.11B | 6.22B | 5.96B | 5.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.89B | 6.11B | 6.22B | 5.96B | 5.56B |
| Cost of Revenue | 2.37B | 2.57B | 2.46B | 2.53B | 2.25B |
| Gross Profit | 3.52B | 3.54B | 3.76B | 3.44B | 3.31B |
| SG&A Expenses | 1.74B | 1.79B | 1.71B | 1.68B | 1.56B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -52.10M | -58.20M | -149.65M | 137.33M | 126.81M |
| Total Operating Expenses | 4.82B | 5.03B | 4.79B | 4.95B | 4.51B |
| Operating Income | 1.07B | 1.08B | 1.43B | 1.01B | 1.04B |
| Income Before Tax | 996.91M | 466.80M | 1.31B | 940.86M | 1.01B |
| Income Tax Expenses | 229.52M | 89.64M | 263.05M | 197.48M | 229.31M |
| Earnings from Continuing Operations | 767.39M | 377.17M | 1.05B | 743.38M | 776.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.67M | -5.82M | 4.68M | -3.40M | -2.74M |
| Net Income | 756.72M | 371.35M | 1.05B | 739.97M | 773.79M |
| EBIT | 1.07B | 1.08B | 1.43B | 1.01B | 1.04B |
| EBITDA | 1.63B | 1.52B | 1.96B | 1.50B | 1.52B |
| EPS Basic | 1.74 | 0.85 | 2.42 | 1.70 | 1.78 |
| Normalized Basic EPS | 1.41 | 1.83 | 1.89 | 1.35 | 1.44 |
| EPS Diluted | 1.74 | 0.85 | 2.42 | 1.70 | 1.78 |
| Normalized Diluted EPS | 1.41 | 1.83 | 1.89 | 1.35 | 1.44 |
| Average Basic Shares Outstanding | 433.82M | 434.80M | 435.75M | 434.67M | 435.09M |
| Average Diluted Shares Outstanding | 433.82M | 434.80M | 435.75M | 434.67M | 435.09M |
| Dividend Per Share | -- | 2.56 | -- | -- | -- |
| Payout Ratio | 2.06% | 0.00% | -- | 152.30% | 6.26% |